Mechanisms of disease: Mechanisms of bone metastasis

被引：1652

作者：

Roodman, GD

机构：

[1] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15213 USA

[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA

[3] Dept Vet Affairs Med Ctr, Pittsburgh, PA USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 350卷 / 16期

关键词：

D O I：

10.1056/NEJMra030831

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1655 / 1664

页数：10

共 88 条

[81] Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction:: Elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases [J].

Van der Pluijm, G ;

Sijmons, B ;

Vloedgraven, H ;

Deckers, M ;

Papapoulos, S ;

Löwik, C .

JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (06) :1077-1091

[82] Evaluation of bone metabolic markers in breast cancer with bone metastasis [J].

Wada N. ;

Fujisaki M. ;

Ishii S. ;

Ikeda T. ;

Kitajima M. .

Breast Cancer, 2001, 8 (2) :131-137

[83] Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors:: Synergistic activation of differentiation, cell spreading, and fusion [J].

Wani, MR ;

Fuller, K ;

Kim, NS ;

Choi, YW ;

Chambers, T .

ENDOCRINOLOGY, 1999, 140 (04) :1927-1935

[84] Overview of bone morphogenetic proteins [J].

Wozney, JM .

SPINE, 2002, 27 (16) :S2-S8

[85] Transcription factors in bone: developmental and pathological aspects [J].

Yang, XL ;

Karsenty, G .

TRENDS IN MOLECULAR MEDICINE, 2002, 8 (07) :340-345

[86] Osteoclast differentiation factor is a ligand for osteoprotegerin osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL [J].

Yasuda, H ;

Shima, N ;

Nakagawa, N ;

Yamaguchi, K ;

Kinosaki, M ;

Mochizuki, S ;

Tomoyasu, A ;

Yano, K ;

Goto, M ;

Murakami, A ;

Tsuda, E ;

Morinaga, T ;

Higashio, K ;

Udagawa, N ;

Takahashi, N ;

Suda, T .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (07) :3597-3602

[87]

Yi B, 2002, CANCER RES, V62, P917

[88] TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development [J].

Yin, JJ ;

Selander, K ;

Chirgwin, JM ;

Dallas, M ;

Grubbs, BG ;

Wieser, R ;

Massagué, J ;

Mundy, GR ;

Guise, TA .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :197-206

← 1 2 3 4 5 6 7 8 9 →